HEAL Covered Call Strategy
HEAL (Global X HealthTech ETF), in the Financial Services sector, (Asset Management industry), listed on NASDAQ.
HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. The underlying index screens for companies that are found in FactSet industries identified by the index administrator as relating to healthcare technology and derive at least 50% of their revenue from one or more of the subthemes. Prior to April 1, 2025, the fund tracked a narrower index targeting telemedicine and digital health, the Solactive Telemedicine & Digital Health Index. The fund name was Global X Telemedicine & Digital Health ETF and traded using the ticker EDOC.
HEAL (Global X HealthTech ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $41.1M, a beta of 1.54 versus the broader market, a 52-week range of 23-33.59, average daily share volume of 8K, a public-listing history dating back to 2020. These structural characteristics shape how HEAL etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.54 indicates HEAL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. HEAL pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on HEAL?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current HEAL snapshot
As of June 30, 2026, spot at $28.01, ATM IV 82.60%, IV rank 47.16%, expected move 23.68%. The covered call on HEAL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this covered call structure on HEAL specifically: HEAL IV at 82.60% is mid-range versus its 1-year history, so the credit collected on a HEAL covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 23.68% (roughly $6.63 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HEAL expiries trade a higher absolute premium for lower per-day decay. Position sizing on HEAL should anchor to the underlying notional of $28.01 per share and to the trader's directional view on HEAL etf.
HEAL covered call setup
The HEAL covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HEAL near $28.01, the first option leg uses a $29.41 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HEAL chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HEAL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $28.01 | long |
| Sell 1 | Call | $29.41 | N/A |
HEAL covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
HEAL covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on HEAL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on HEAL
Covered calls on HEAL are an income strategy run on existing HEAL etf positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
HEAL thesis for this covered call
The market-implied 1-standard-deviation range for HEAL extends from approximately $21.38 on the downside to $34.64 on the upside. A HEAL covered call collects premium on an existing long HEAL position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether HEAL will breach that level within the expiration window. Current HEAL IV rank near 47.16% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on HEAL should anchor more to the directional view and the expected-move geometry. As a Financial Services name, HEAL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HEAL-specific events.
HEAL covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HEAL positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HEAL alongside the broader basket even when HEAL-specific fundamentals are unchanged. Short-premium structures like a covered call on HEAL carry tail risk when realized volatility exceeds the implied move; review historical HEAL earnings reactions and macro stress periods before sizing. Always rebuild the position from current HEAL chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on HEAL?
- A covered call on HEAL is the covered call strategy applied to HEAL (etf). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With HEAL etf trading near $28.01, the strikes shown on this page are snapped to the nearest listed HEAL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are HEAL covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the HEAL covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 82.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HEAL covered call?
- The breakeven for the HEAL covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HEAL market-implied 1-standard-deviation expected move is approximately 23.68%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on HEAL?
- Covered calls on HEAL are an income strategy run on existing HEAL etf positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current HEAL implied volatility affect this covered call?
- HEAL ATM IV is at 82.60% with IV rank near 47.16%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.